Impulsivity, a multifaceted behavioral hallmark of attention-deficit/hyperactivity disorder (ADHD), strongly influences addiction vulnerability and other psychiatric disorders that incur enormous medical and societal burdens yet the neurobiological underpinnings linking impulsivity to disease remain poorly understood. Here we report the critical role of ventral striatal cAMP-response element modulator (CREM) in mediating impulsivity relevant to drug abuse vulnerability. Using an ADHD rat model, we demonstrate that impulsive animals are neurochemically and behaviorally more sensitive to heroin and exhibit reduced Crem expression in the nucleus accumbens core. Virally increasing Crem levels decreased impulsive action, thus establishing a causal relationship. Genetic studies in seven independent human populations illustrate that a CREM promoter variant at rs12765063 is associated with impulsivity, hyperactivity and addiction-related phenotypes. We also reveal a role of Crem in regulating striatal structural plasticity. Together, these results highlight that ventral striatal CREM mediates impulsivity related to substance abuse and suggest that CREM and its regulated network may be promising therapeutic targets.
INTRODUCTION
Impulsivity is a symptom that spans psychiatric diagnostic boundaries comprising risky behavior, unreflective decisionmaking, premature actions and deficits in delaying gratification. 1 It is notably a core feature of attention-deficit/hyperactivity disorder (ADHD) and highly comorbid with substance use disorders (SUDs). [2] [3] [4] [5] [6] [7] Multiple human and animal investigations show a strong relationship between pre-existing impulsivity traits and SUD vulnerability. Psychostimulants are the drug class mainly examined with impulsivity, but recent clinical evidence suggests that heroin-dependent individuals also exhibit greater impulsivity and sensation-seeking traits, [8] [9] [10] which is significant considering that opiates are the second most abused illicit drugs in the USA. 11 Although the neurobiology relating impulsivity with SUD is unknown, frontostriatal and mesocorticolimbic circuits that mediate decision-making and motivation likely have critical roles. 12, 13 The nucleus accumbens (Acb) is an important neuroanatomical hub within these circuits given that the core (AcbC) and shell (AcbSh) subregions modulate different components of impulsivity, such as impulsive choice, reflecting cognitive impulsivity and impulsive action, reflecting motor impulsivity and inhibitory control. [14] [15] [16] [17] [18] The molecular underpinnings of drug addiction vulnerability within specific Acb subregions relevant to distinct impulsive behavioral domains remain unknown.
Here, we used a multidisciplinary approach to identify neurobiological substrates of impulsivity associated with opiate abuse. We demonstrate that spontaneously hypertensive rats (SHRs), a common ADHD model, have greater behavioral and neurochemical sensitivity to heroin. Using this model revealed a critical role of the transcription factor Crem in the AcbC in mediating impulsive action with epigenetic and genetic factors contributing to its regulation. Studying multiple human cohorts, we showed associations between CREM polymorphism and impulsivity, hyperactivity and substance abuse in individuals with ADHD and SUD. We identified a molecular network associated with Crem related to synaptic plasticity and directly demonstrated that Crem regulates dendritic morphology. Altogether, this translational study provides a novel molecular target for components of impulsivity trait important for substance abuse.
MATERIALS AND METHODS

Animal models and behavioral tasks
Animals. The male SHRs and Wistar-Kyoto rats (WKYs), obtained from Charles River Laboratories (Raleigh, NC, USA), were housed in a humidityand temperature-controlled environment on a reversed 12 h light/dark cycle (lights off at 0900 h) with ad libitum access to food and water. All the procedures were conducted in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals and approved by the Institutional Animal Care and Use Committee at the Icahn School of Medicine at Mount Sinai, New York, NY, USA. For surgical procedures, see Supplementary Information.
Behavioral tasks. Impulsivity was studied using a temporal discounting task known as intolerance to delay (ITD) during which animals selected either an immediate single-pellet or a delayed five-pellet reward. Novelty-seeking and heroin-induced locomotor activity were assessed in open-field arenas. For self-administration (SA) experiments, the rats were trained to intravenously self-administer heroin, then underwent extinction training and cue-induced reinstatement. For details, see Supplementary Information.
In vivo neurochemistry, molecular biology and cell culture Dopamine concentration after acute heroin injection was measured from AcbC of SHRs and WKYs using in vivo microdialysis and high-performance liquid chromatography. Gene expression was measured from Acb of SHRs and WKYs using quantitative PCR with reverse transcription. Epigenetic modifications near Crem were assessed in Acb of SHRs and WKYs using either chromatin immunoprecipitation and quantitative PCR, or bisulfite conversion and sequencing. Primary cortical and striatal neurons derived from Long-Evans embryos were co-cultured for dendritic neuromorphology. For details, see Supplementary Information.
Human genetic studies
Association studies were performed to understand the relationship between CREM and traits related to impulsivity. All participants provided informed consent and studies were conducted in accordance with institutional approval (Queens College, CUNY, for preschool and adolescent ADHD studies; Wayne State University for postmortem opiate use studies; Semmelweis University, Hungary, for postmortem heroin use studies; and Icahn School of Medicine at Mount Sinai, New York, for cannabis dependence studies). For details and demographics, see Supplementary Information.
Statistical analyses
Data are expressed as mean (± s.e.m.) unless otherwise indicated and statistical analyses, as detailed in Supplementary Information, were performed using SPSS (v22 (IBM, Chicago, IL, USA)), GraphPad Prism (v6 (GraphPad Software, La Jolla, CA, USA)) , and PLINK (v1.06). 19 The sample sizes for animal studies were determined based on experience of effects typically encountered in behavioral and molecular studies, whereas human studies were based on previously published data sets. For details, see Supplementary Information.
RESULTS
ADHD animal model characterized by enhanced impulsivity and heroin sensitivity
To better understand the relationship between behavioral traits and addiction vulnerability, we first characterized SHRs to discern different aspects of impulsivity relevant to human substance abuse. As SHRs are genetically derived from WKYs, these animals were used as controls. The animals performed a temporal discounting task (ITD) that measured choice between an immediate small reward (one food pellet) and a delayed large reward (five food pellets; Supplementary Figure 1 ). The delay length was gradually increased during the test phase and impulsive choice was reflected by relative preference for the immediate reward ( Supplementary Figure 1c ). Both SHRs and WKYs decreased preference for the large reward as delay increased (F 6,174 = 53.76, Po 0.001). This relative shift in preference towards the smaller, immediate reward was, however, significantly faster in impulsive rats (F 6,174 = 3.05, P = 0.007) confirming that SHRs exhibit elevated impulsive choice (Figure 1a and Supplementary Figure 2a ). Lever presses were also recorded during the delay period, after pressing L5 but before receiving food. Although intra-delay presses did not result in additional food delivery, shifting responses to L1 during this period reflected impulsive action ( Supplementary Figure 1d ). Although both strains displayed more intra-delay L1 presses as the delay increased (F 5,145 = 36.73, P o0.001), this increase was more pronounced in SHRs (F 5,145 = 10.55, P o 0.001), consistent with this strain's elevated impulsive action ( Figure 1b ). As the delay period strictly followed L5 presses, not L1, perseveration on this lever during the delay was used to distinguish compulsivity from impulsive action. Thereby, intra-delay L5 presses also increased in both strains during the testing phase (F 5,145 = 27.13, P o 0.001) and, although there was a strain × time interaction (F 5,145 = 2.83, P = 0.02), post (e-h) Impulsive SHRs also exhibit elevated heroin self-administration (e) and cumulative intake (f), attenuated extinction (g) and enhanced reinstatement (h; n = 5 SHR and 6 WKY). All data are expressed as mean ± s.e.m. *P o0.05, **P o0.01, ***P o0.001 relative WKY; † Po 0.05, † † † Po 0.001 relative extinction day; independent or paired t-tests with Holm-Šidák correction, see results text for ANOVA statistics. AcbC, core of the nucleus accumbens; ANOVA, analysis of variance; ITD, intolerance to delay; SHR, spontaneously hypertensive rat; WKY, Wistar-Kyoto rat.
hoc analysis did not reveal significant differences between strains during any session ( Supplementary Figure 2b ). Similar pressing patterns were observed during the fixed time-out period-during which a cue signaled the unavailability of a reward-and responses on L1 were significantly different between SHRs and WKYs (F 1,29 = 32.79, P o 0.001, Supplementary Figure 2c ).
In addition to these behavioral measures of impulsivity, SHRs exhibited increased hyperactivity during ITD (F 1,29 = 49.22, Figure 2 . Crem in the AcbC alters impulsive action and associates with genetic and epigenetic alterations in impulsive animals. (a) Crem was reduced in the Acb of drug-naive SHRs, specifically in the AcbC but not AcbSh (inset; for array, n = 6 per group; for single-assay validation, n = 6 per group for AcbC, 5 SHR and 6 WKY for AcbSh). (b) Acute heroin-induced Crem in the AcbC of SHRs but not WKYs, while in the AcbSh, heroin produced similar increases in both strains (n = 6 SHR and 5 WKY and shown relative saline-treated animals in a). (c) To study the causal contribution of Crem to impulsivity, HSV-Crem-Gfp was infused into the AcbC of SHRs resulting in overexpression (n = 4 Gfp and 5 Crem-Gfp, 2 independent experiments). (d-f) Although overexpression did not impact preference for the large reward (d), it decreased errors of commission during ITD (e) and inactive lever pressing during heroin self-administration (f; for ITD, n = 5 Gfp and 7 Crem-Gfp; for SA, n = Gfp and 6 Crem-Gfp). (g-i) In the AcbC of SHRs, the permissive histone marks AcH3 (g) and H3K4me3 (h) were depleted near the Crem transcriptional start site (TSS), whereas DNA methylation was elevated upstream within the promoter (i) (n = 8 per group for ChIP, 8-10 per group for methylation). (j) Schematic of the rat Crem illustrating exons (numbered black bars), conserved regions (gray bars) and PCR primers used for ChIP-qPCR (top), bisfulfite sequencing (middle) and Sanger sequencing (bottom), all numbered relative to the TSS. Single-nucleotide polymorphism within the first noncoding exon of rat Crem (indicated by •). Sequencing results from outbred Long-Evans (LE) strain are shown for reference. All data are expressed as mean ± s.e.m. *P o0.05, **Po 0.01, ***P o0.001 relative WKY or Gfp alone; † † † P o0.001 relative vehicle treatment (shown as horizontal line); independent t-tests with Holm-Šidák correction (for behavior) and Fisher's LSD (for qCPR), see results text for ANOVA statistics. AcbC, core of the nucleus accumbens; AcbSh, shell of the nucleus accumbens; ANOVA, analysis of variance; ChIP, chromatin immunoprecipitation; ITD, intolerance to delay; LSD, least significant difference; qPCR, quantitative PCR; SA, self-administration; SHR, spontaneously hypertensive rat; WKY, Wistar-Kyoto rat.
Ventral striatal regulation of CREM mediates impulsivity P o0.001, Supplementary Figure 2d ) and increased novelty seeking when placed in a novel open-field arena (F 1,14 = 22.10, P o0.001, Figure 1c ). Moreover, SHRs were more sensitive to heroin's acute neurochemical and behavioral effect. Although there was no baseline difference in extracellular dopamine levels in the AcbC between the two strains (t 8 = 1.10, P = 0.30), SHRs exhibited a more pronounced heroin-induced increase (F 9,72 = 3.39, P = 0.002, Figure 1d , upper panel), consistent with their enhanced locomotor response (F 8,96 = 6.18, P o 0.001, Figure 1d , lower panel).
We next directly tested whether impulsive SHRs were more vulnerable to heroin addiction using a drug SA task that models different components of the abuse cycle. Although lever pressing did not initially differ between the strains, SHRs pressed more on both active (F 1,9 = 18.62, P = 0.002, Figure 1e ) and inactive levers (F 1,9 = 5.11, P = 0.05, Figure 1e ) during the maintenance phase, and therefore cumulatively consumed more heroin than WKYs (t 9 = 4.31, P = 0.002, Figure 1f ). Despite their clear preference for the active lever, SHRs showed diminished motor inhibition evident by greater inactive lever pressing relative WKYs, which is in line with their elevated impulsive action as measured in the ITD task. Although differences in inactive lever pressing could represent the strains' baseline differences in locomotor activity, this does not fully explain the SA data as there was no correlation between inactive lever responses and general locomotion (Supplementary Figure 3 ).
After stable maintenance, the animals underwent an extinction phase at which time responses on the previously reinforced lever resulted in saline delivery, not heroin. As expected, lever pressing decreased over time in both strains (F 16,128 = 10.27, P o 0.001, Figure 1g ), yet as evident by nonlinear regression, SHRs extinguished at a slower rate (k parameter: t 32 = 2.84, P = 0.008) and to a lesser extent (plateau parameter: t 32 = 3.41, P = 0.002). Following extinction, reinstatement liability was determined by exposing the animals to a non-extinguished cue previously associated with heroin delivery. The drug-associated cue promoted heroin-seeking behavior in both strains (F 1,8 = 37.61, P o0.001), but SHRs exhibited enhanced heroin-seeking with a larger number of active lever presses than WKYs (t 8 = 2.64, P = 0.03, Figure 1h ). Overall, these results demonstrate that SHRs have greater dopamine sensitivity to heroin, maintain higher levels of heroin intake, exhibit decreased capacity to extinguish their drug intake and have a greater tendency for relapse, all supporting the hypothesis of enhanced drug addiction sensitivity associated with the impulsive phenotype.
Reduced AcbC Crem expression mediates impulsive action Given the central role of the AcbC in behaviors related to impulsivity and drug addiction, 20,21 our next goal was to identify molecular underpinnings of SHRs' impulsive predisposition. Of the genes related to synaptic plasticity and neurotransmission included in our expression panel, the transcription factor Crem showed the greatest difference (t 10 = 3.62, P = 0.005, Figure 2a and Supplementary Table 1 ). The decrease, specific to the AcbC (Figure 2a inset), was verified using an independent quantitative PCR with reverse transcription assay (t 10 = 3.31, P = 0.008) and reproduced in a separate cohort of animals (t 15 = 2.22, P = 0.042). Interestingly, acute heroin (1 mg kg −1 , intraperitoneal) increased Crem mRNA expression in the AcbC of SHRs (t 10 = 8.54, P o 0.001) but not WKYs (t 9 = 0.172, P40.05), while Crem was equally induced in the AcbSh of both strains (Figure 2b) .
We next overexpressed Crem in the AcbC of SHRs and evaluated ITD and heroin SA to determine this gene's potential causal relationship to impulsivity and related behavior. For ITD, HSV-Crem-Gfp or HSV-Gfp (Gfp alone) was bilaterally infused into the AcbC 1 day before the start of testing ( Supplementary Figure 4a) . Compared with control, HSV-Crem-Gfp infusion elevated Crem expression (t 7 = 2.56, P = 0.038, Figure 2c ) but did not alter choice for large reward (Figure 2d, Supplementary Figure 4b ) or locomotor activity ( Supplementary Figure 4e) . Instead, these animals exhibited lower intra-delay L1 responses as the delay increased (F 5,50 = 2.40, P = 0.05, Figure 2e ), whereas neither intradelay L5 pressing (F 5,50 = 2.32, P = 0.06, Supplementary Figure 4c ) nor L1 pressing during the time-out period (F 1,10 = 0.52, P = 0.49, Supplementary Figure 4d ) differed between groups. These data show that AcbC Crem specifically reduced L1 responses during the delay period and suggest an association with impulsive action, not impulsive choice, compulsivity or general hyperactivity. For heroin SA, HSV-Crem-Gfp or HSV-Gfp was bilaterally infused into the AcbC of a different cohort of animals the day before the first session. Overexpression did not impact responses on the heroinassociated active lever but significantly decreased inactive lever pressing (F 1,9 = 13.50, P = 0.005, Figure 2f ). These data indicate that AcbC Crem does not affect heroin reinforcement per se but decreases impulsive action in the context of a reward-related behavior.
Epigenetic and genetic signature of Acb Crem differs in impulsive animals Epigenetic factors tightly regulate gene expression and thereby could contribute to the subregionally specific deficit in Crem observed in SHRs. To explore this hypothesis, we studied histone post-translational modifications which have well-documented roles in transcriptional regulation. Chromatin from the AcbC and AcbSh were immunoprecipitated with antibodies specific for panacetylated histone H3 (H3Ac) and trimethylated histone 3 lysine 4 (H3K4me3), both typically markers of transcriptional activation, and dimethylated histone 3 lysine 9 (H3K9me2), a repressive marker. The profile of H3Ac revealed lower enrichment of this mark close to the transcriptional start site (TSS) in the AcbC of SHRs (t 13 = 3.05, P = 0.009, Figure 2g and Supplementary  Figure 5a ), but not the AcbSh (t 14 = 0.72, P40.05, Supplementary  Figure 5d ). Similarly, lower H3K4me3 enrichment was observed in the AcbC of SHRs around the TSS (−0.05 kb relative TSS, t 13 = 2.98, P = 0.01) and in a downstream region (+0.17 kb relative TSS, t 13 = 2.49, P = 0.02, Figure 2h and Supplementary Figures 5b  and e ). Enrichment of H3K9me2 showed no difference between the rat strains at any examined loci except +0.17 kb downstream the TSS in the AcbSh (t 14 = 3.31, P = 0.005, Supplementary Figures  5c and f) . These region-specific epigenetic changes are in line with the transcriptional differences observed between the strains. Concomitant with the histone post-translation modifications, SHRs exhibited greater cytosine methylation immediately upstream the TSS within a conserved CpG island (t 16 = 2.60, P = 0.019), but not within the gene body (t 18 = 0.74, P = 0.47, Figure 2i ).
As DNA sequence may account for differences in expression, we sequenced the region of Crem with differences in histone modification and identified a noncoding single-nucleotide polymorphism in the first exon unique to SHRs (Figure 2j ). Altogether, these data suggest that SHRs exhibit distinct epigenetic modifications in the AcbC as well as a unique genetic variant within the Crem gene that provides a potential bridge for human phenotypes.
Genetic variants of CREM associate with impulsivity and substance use in human populations
To determine whether CREM relates to impulsivity and addiction vulnerability in humans, we studied CREM genotype in relation to behavior guided by the animal findings. We performed a set of independent, hypothesis-driven association studies focused on a variant within the CREM gene (rs12765063) that was similarly positioned within the CREM locus when compared with the rodent polymorphism (Figure 2j ). This variant was within a conserved region of the promoter, in strong linkage disequilibrium with the surrounding region, and enriched with H3K27Ac and H3K4me3 in the striatum, 22 all suggesting the presence of adjacent regulatory features ( Supplementary Figure 7) .
We first investigated the relationship between opiate abuse and striatal CREM by studying two independent postmortem opiate abuse populations. In the first population, composed of an ethnically heterogeneous US population, 23, 24 rs12765063 was associated with elevated risk of opiate abuse (χ 2 = 24.30, Po 0.0001, Figure 3a inset). To eliminate the possibility that this pronounced effect was due to ancestral differences between the two groups, we separately analyzed on the basis of race and still detected significant associations (Mantel-Haenszel Test, χ 2 = 5.03, P = 0.025, Figure 3a) . In an independent, ethnically homogenous European population, 25 rs12765063 associated with measures of abuse severity, namely years of use preceding lethal intoxication (t 43 = 2.16, P = 0.036, Figure 3b ) and history of previous overdose (χ 2 = 4.32, P = 0.038, Figure 3c ), but not heroin abuse (χ 2 = 0.31, P = 0.58). These data suggest that CREM associates with hazardous patterns of opioid use and a more rapid progression to lethal intoxication. In a large COGA data set 26 for which use of other substances was measured, rs12765063 significantly associated with DSM-IV alcohol dependence symptom count (β = 0.063, P = 0.002), and total symptom count for alcohol, marijuana, cocaine and opiate dependence (β = 0.062, P = 0.04, Figure 3d ). These observations suggest that CREM genotype broadly influences risk for drug dependence, rather than being specific for opiate abuse, and laid the foundation for our follow-up studies focused on ADHD and addiction vulnerability.
To gain insights into the relationship between impulsivity and CREM as relevant to addiction vulnerability, we examined three independent, longitudinal ADHD populations, each with agematched controls. First, in preschool-aged children both with and without diagnosed ADHD, 27 rs12765063 associated with impulsive behavioral traits, namely distractibility (β = 1.14, t 127 = 2.54, P = 0.01), engaging in dangerous activities (β = 1.20, t 127 = 2.41, P = 0.02) and failing to listen to instruction (β = 1.13, t 127 = 2.32, P = 0.02, Figure 4a ). In the second population composed of adolescents (~18 years old) with ADHD studied since the age of~9 years, 28 rs12765063 strongly associated with measures of hyperactivity, namely ankle movement during neuropsychological testing (β = 53.41, t 127 = 2.59, P = 0.011, Figure 4b ) and selfreported hyperactivity (β = 4.26, t 138 = 2.29, P = 0.023, Figure 4c ). In this adolescent population, use of alcohol, cigarettes, marijuana and non-prescribed psychostimulants were measured revealing a significant ADHD × rs12765063 interaction (F 1,138 = 5.35, P = 0.02, Supplementary Figure 8a) . In more detail, drug use was considerably greater in ADHD subjects with the A-allele compared with controls with the same allele (t 138 = 2.15, P = 0.03). As ADHD severity may change over time, the subjects were stratified based on the presence or absence of ADHD symptoms at follow-up, which again revealed a strong interaction between the CREM polymorphism and ADHD persistence (F 2,136 = 4.35, P = 0.02, Figure 4d ). Specifically, past drug use was significantly elevated in A-allele carriers with persistent symptomology when compared with controls (t 136 = 2.61, P = 0.02), but there was no difference between those in remission and controls (t 136 = 0.69, P = 0.49). Similar interactions were observed in a larger independent population of 1054 adolescents from IMAGEN. 29 After correcting for gender, age and ethnicity, there were significant ADHD × rs12765063 interactions with respect to the number of individuals reporting any lifetime use (β = 0.93, χ 2 = 4.57, P = 0.03, Supplementary Figure 8b ) and the amount of use by those reporting any use (F 1,361 = 3.96, P = 0.05, Supplementary Figure 8c ).
We next leveraged data from a published study in which neuropsychological and behavioral measures were collected in adult drug (cannabis)-dependent and non-dependent subjects. 30 In more details, rs12765063 significantly associated with increased impulsivity (β = 3.21, t 97 = 3.33, P = 0.001) and decreased persistence (β = − 12.12, t 97 = − 2.25, P = 0.027, Figure 4e) , with the association with impulsivity particularly strong in dependent individuals (β = 3.71, t 48 = 3.46, P = 0.001, Supplementary  Figure 9a ). Based on statistical mediation modeling, impulsivity mediated the association between CREM and dependence severity (P M = 77%, Z = 2.88, P = 0.004, Figure 4f and Supplementary Figure 9b ) even after incorporating self-reported race, gender and age as covariates (P M = 63%, Z = 2.72, P = 0.007). No other trait except negative affect (β = 3.63, t 97 = 2.55, P = 0.013) associated with this polymorphism. Overall, these findings support a genotype-phenotype association between CREM and impulsivity in the genetic link to addiction vulnerability.
CREM regulation relates to neuroplasticity and dendritic spine morphology
To determine neuronal networks related to both impulsivity and heroin abuse, we compared differentially expressed genes derived from two ventral striatal microarrays-human heroin abusers versus matched controls and SHRs versus WKYs. Although only Figure 3 . Genetic variation in CREM associates with substance use. (a) In a postmortem population composed of individuals with opiate abuse, the rs12765063 variant associated with increased risk of opiate abuse even after stratifying on the basis of ethnicity. (b) In our well-curated postmortem brain collection composed of ethnically homogenous heroin abusers, this variant associated with shorter duration of drug use, which, given the fact that brains were collected at death due to opiate overdose, suggests that individuals with the A-allele more rapidly progressed to lethal intoxication. (c) This is consistent with the finding that A-allele carriers were also more likely to experience a previous, albeit non-lethal overdose. (d) The additive genotypic effect of the A-allele on higher total number of symptoms for any drug dependence can clearly be seen. Homozygotes for the G/G genotype had an average 2.38 ± 0.08 symptoms while homozygotes for the A/A genotype had an average of 3.36 ± 0.61 symptoms. All data are expressed as mean ± s.e.m. unless otherwise indicated on y axis. For sample sizes, see Supplementary Table 4 . *P o0.05, ****P o0.0001 relative control participants; † P o0.05, relative G/G genotype; independent t-tests with Holm-Šidák correction (versus control participants) or Fisher's LSD (versus G/G), see results text for linear and nonlinear regression. CI, confidence interval; LSD, least significant difference.
6.8% of the differentially expressed genes overlapped (Figure 5a , Supplementary Table 2) , not surprising given the clear differences in phenotype, the 442 shared genes were disproportionately targets of CREM and regulators of neuroplasticity related to actin cytoskeleton and focal adhesion (Figure 5b and Supplementary  Table 2 ). Intriguingly, this analysis highlighted adhesion-like G-protein-coupled receptor-3 (Adgrl3), an adhesion G-protein coupled-receptor highly expressed in the striatum and implicated with ADHD. 31 Similar to Crem, SHRs exhibited significantly reduced AcbC Adgrl3 at baseline (t 18 = 3.63, P = 0.002, Figure 5c ), but were more sensitive to heroin's acute effect (F 1,19 = 5.31, P = 0.033, Figure 5c ).
To explore the functional relationship between Crem and neuroplasticity identified in our network analysis, Crem was overexpressed in primary striatal neurons and structural neuromorphology was assessed. Neurons overexpressing Crem showed a profound attenuation in the normal spine developmental observed between 7 and 14 days in vitro. Crem overexpressing medium spiny neurons (marked by DARPP-32 immunoreactivity) exhibited significantly less total dendritic spines at 14 days in vitro when compared with controls (F 1,16 = 14.07, P = 0.002, Figure 5d ), yet there was no difference at 7 days in vitro (F 1,13 = 0.04, P = 0.85, Figure 5d ). This effect was most pronounced for thin spines that, given their more plastic and dynamic nature, were more abundant in developing neurons (Figure 5d ). These data suggest that Crem is a key regulator of spine morphology and development in striatal medium spiny neurons.
DISCUSSION
Our translational study provides direct neurobiological evidence for a causal relationship between the transcription factor Crem in the AcbC and motor impulsivity relevant to ADHD and SUD. Studying a genetically homogeneous inbred animal model and various human cohorts, we demonstrate that (i) impulsivity was associated with vulnerability to heroin abuse and reduced AcbC Crem expression, (ii) AcbC Crem specifically mediated impulsive action and (iii) striatal Crem regulated spine morphology and neuroplasticity. Although Crem expression in the AcbC was not a sufficient regulator of opiate reward sensitivity, it may contribute to factors related to severity and predisposition given that impulsivity mediated the genetic association between CREM and substance use. The fact that CREM genotype was not specific to one drug type suggests it relates to more general aspects of addiction vulnerability.
In contrast to CREB-a prominently studied member of CREbinding transcription factors 32 -few neurobiological investigations have focused on CREM. This paucity may be partly due to the relatively lower and more restricted abundance of CREM in the brain and the complexity of CREM isoforms for which activator or repressor activities are not fully understood. 33, 34 Despite the strong sequence homology, Creb1 was not significantly altered in the AcbC of SHRs ( Supplementary Table 1 ). Our findings demonstrate a reproducible genetic association between CREM genotype and hyperactivity in humans, in line with some locomotor patterns observed in knockout mice. 35 Although our Supplementary Table 4 . *Po 0.05, ***P o0.001, ****P o0.0001 relative control participants; † P o0.05, † † P o0.01, † † † Pr 0.001 relative G/G genotype; independent t-tests with Holm-Šidák correction (versus control participants) or Fisher's LSD (versus G/G), see results text for linear and nonlinear regression. ADHD, attention-deficit/hyperactivity disorder; LSD, least significant difference.
animal studies demonstrated that Crem in the AcbC-the motor component of the ventral striatum-specifically mediates impulsive action, not general activity or impulsive choice, it is possible that CREM expression in other striatal subregions contributes to different features of impulsivity. Moreover, it will be important to assess the impact of long-term perturbation of Crem on behavior using viral vectors with persistent expression.
The initial identification of CREM based on our animal studies was supported by an independent bioinformatic evaluation of overlapping genes, which revealed that the most significant network shared between impulsivity and heroin abuse related to CREM. Intriguingly, the results of this approach were validated by the presence of ADGRL3, previously known as Latrophilin-3 (LPHN3), which has recently been strongly implicated in ADHD. 31, 36 ADGRL3 is thought to transynaptically regulate excitatory synapses 37 and the SHRs' reduced AcbC Adgrl3 expression is consistent with the finding that decreased Lphn3 activity elicits ADHD-like behavior. 38 Dysregulated actin cytoskeleton, a process tightly coupled to dendritic spine morphology, was also identified in our network analysis. As the role of CREM in striatal cytoarchitecture was not previously recognized in studies of addiction, our finding that Crem directly regulates dendritic spine morphology in medium spiny neurons opens new avenues of research.
To our knowledge, this is the first study demonstrating a role of Crem in mediating impulsive behavior. Although altering Crem expression in the AcbC on its own was not sufficient to influence heroin intake or relapse potential, it may be an important component of the neural system underlying addiction vulnerability via impulsivity. Overall, the current translational approach brings attention to CREM in the AcbC as a regulator of impulsive action and therefore may help to identify novel pharmacotherapeutic targets in the treatment of ADHD and SUDs. Figure 5 . Impulsivity and heroin abuse share a common ventral striatal gene expression network that relates to CREM and neuroplasticity. (a and b) To focus on networks related to both impulsivity and heroin abuse, we compared differentially expressed genes derived from two data sets. Although there was only a modest overlap between heroin and SHR altered genes (a), the shared genes are disproportionately regulators of neuroplasticity (b, upper panel) and targets of Crem (b, lower panel). (c) Of these common genes, Adgrl3-a gene previously associated with ADHD-is differentially regulated in the AcbC of SHRs at baseline and after acute heroin exposure (n = 10 per group for baseline study, n = 6 SHR and 5-6 WKY for acute heroin study). (d) Primary striatal neurons (co-cultured with cortical neurons) overexpressing Crem for 2 days in vitro (DIV) exhibited significantly less dendritic spines at DIV14 (St = Stubby, Th = Thin, Mu = Mushroom; n = 11 cells per group from two to three independent experiments). All data are expressed as mean ± s.e.m. unless otherwise indicated on x axis. ***P o0.001 relative WKY or Gfp alone; † P o0.05 relative vehicle; independent t-tests with Holm-Šidák correction, see results text for ANOVA statistics. ADHD, attention-deficit/hyperactivity disorder; ANOVA, analysis of variance; SHR, spontaneously hypertensive rat; WKY, Wistar-Kyoto rat.
